Polypharmacy management in older patients
RW Hoel, RMG Connolly, PY Takahashi - Mayo Clinic Proceedings, 2021 - Elsevier
Medications to treat disease and extend life in our patients often amass in quantities,
resulting in what has been termed “polypharmacy.” This imprecise label usually describes …
resulting in what has been termed “polypharmacy.” This imprecise label usually describes …
Sleep disorders in the elderly: Diagnosis and management
K Suzuki, M Miyamoto, K Hirata - Journal of general and family …, 2017 - Wiley Online Library
Compared with younger people, elderly people show age‐related sleep changes, including
an advanced sleep phase and decreased slow‐wave sleep, which result in fragmented …
an advanced sleep phase and decreased slow‐wave sleep, which result in fragmented …
Benzodiazepine use in the United States
Importance Although concern exists regarding the rate of benzodiazepine use, especially
long-term use by older adults, little information is available concerning patterns of …
long-term use by older adults, little information is available concerning patterns of …
[PDF][PDF] Benzodiazepine use and risk of Alzheimer's disease: case-control study
SB De Gage, Y Moride, T Ducruet, T Kurth, H Verdoux… - Bmj, 2014 - bmj.com
Objectives To investigate the relation between the risk of Alzheimer's disease and exposure
to benzodiazepines started at least five years before, considering both the dose-response …
to benzodiazepines started at least five years before, considering both the dose-response …
[图书][B] Deadly medicines and organised crime: how big pharma has corrupted healthcare
P Gotzsche - 2019 - taylorfrancis.com
PRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART
DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the …
DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the …
[HTML][HTML] Promoting successful cognitive aging: a ten-year update
TJ Krivanek, SA Gale, BM McFeeley… - Journal of …, 2021 - content.iospress.com
A decade has passed since we published a comprehensive review in this journal
addressing the topic of promoting successful cognitive aging, making this a good time to …
addressing the topic of promoting successful cognitive aging, making this a good time to …
[HTML][HTML] Management of benzodiazepine misuse and dependence
Management of benzodiazepine misuse and dependence - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study
SL Gray, S Dublin, O Yu, R Walker, M Anderson… - bmj, 2016 - bmj.com
Objective To determine whether higher cumulative use of benzodiazepines is associated
with a higher risk of dementia or more rapid cognitive decline. Design Prospective …
with a higher risk of dementia or more rapid cognitive decline. Design Prospective …
Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis
Background: Benzodiazepines are a widely used medication in developed countries,
particularly among elderly patients. However, benzodiazepines are known to affect memory …
particularly among elderly patients. However, benzodiazepines are known to affect memory …
Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study
S Weich, HL Pearce, P Croft, S Singh, I Crome… - Bmj, 2014 - bmj.com
Objective To test the hypothesis that people taking anxiolytic and hypnotic drugs are at
increased risk of premature mortality, using primary care prescription records and after …
increased risk of premature mortality, using primary care prescription records and after …